-

BioIVT Expands Capacity With New Cutting-Edge Facility

Company to drive innovation and growth in key biotech market with office opening in Woodbury, NY

BALTIMORE--(BUSINESS WIRE)--BioIVT, a global research partner and biospecimen solutions provider for drug and diagnostic development, today announced a company milestone with a new office space, including a state-of-the-art laboratory in Woodbury, New York. This expansion supports the company’s continued commitment to enabling life-saving research within New York's booming research community and beyond.

This opening comes at a pivotal time, as New York continues to establish itself as a leader in the biotechnology community. With a recent $620 million state grant fueling biotech innovation, the region is witnessing an influx of investment and a surge in industry collaboration. BioIVT’s facility in Woodbury reflects the strength of New York’s thriving life sciences sector while also serving as a global hub for delivering biospecimen solutions to researchers worldwide.

With over 40 years of experience delivering high-quality, personalized biospecimen solutions, BioIVT has helped researchers advance toward breakthroughs that bring life-changing therapies and cures closer to reality. Our new purpose-built facility reflects our ongoing pledge to support the ever-evolving needs of the scientific community now and into the future.

The grand opening celebration will take place on September 18, 2025, with a ribbon-cutting ceremony, company social event, and local government in attendance. Dr. Richard Haigh, CEO at BioIVT, and other distinguished guests will share remarks about the company’s vision and what’s possible through this new office space.

“With our new Woodbury facility, BioIVT is deepening its support for the scientific research community, amplifying our global reach and impact, as well as our commitment to strengthening the local economy,” said Haigh. “The grand opening will be a moment to celebrate the company’s vision for the future, its positive impact on the local community that’s highly invested in innovation, and our team’s dedication to advancing the life sciences sector as a whole.”

The new office is located at 175 Crossways Park Drive West, Suite 200, Woodbury, NY 11797. In addition to this site, BioIVT has 27 global sites providing unmatched sourcing and exceptional services. To learn more about BioIVT’s current career opportunities in New York and around the world, visit https://bioivt.com/careers.

About BioIVT
BioIVT enables smarter science and accelerates medical breakthroughs by delivering high-quality personalized biospecimen solutions and research services to the life science and diagnostic industries. We specialize in control and disease state samples including human and animal tissues or preparations, ADME products and research services, cell and gene therapy products, blood, and other biofluids. Our unmatched portfolio of clinical specimens directly supports precision medicine research and the effort to improve patient outcomes by coupling comprehensive clinical data with donor samples. By combining our technical expertise, exceptional customer service, and unparalleled access to biological specimens, BioIVT serves the research community as a trusted partner in ELEVATING SCIENCE®. For more information, please visit www.bioivt.com or follow us on LinkedIn.

Contacts

BioIVT Contact: Charlie Chungu, Vice President of Marketing, cchungu@bioivt.com
Media Contact: Paige Romine, PAN, 321-652-8370, BioIVT@pancomm.com

BioIVT


Release Versions

Contacts

BioIVT Contact: Charlie Chungu, Vice President of Marketing, cchungu@bioivt.com
Media Contact: Paige Romine, PAN, 321-652-8370, BioIVT@pancomm.com

More News From BioIVT

BioIVT to Explore What’s Next for Oncology Biomarker Discovery at Liquid Biopsy for Precision Oncology East Coast, as Part of Summer Event Circuit

WOODBURY, N.Y.--(BUSINESS WIRE)--BioIVT, a global research partner and biospecimen solutions provider for drug and diagnostic development, today announced that Courtney Noah, PhD, Vice President of Scientific Affairs at BioIVT, will present at Liquid Biopsy for Precision Oncology East Coast in Boston, MA. Her presentation, “The Evolution of Oncology Biomarker Discovery: Why Multi-Omic Strategies are Reshaping Translational Research,” will explore the shift in oncology biomarker discovery from s...

BioIVT Names Sean Downing, PhD, to Scientific Advisory Board

WOODBURY, N.Y.--(BUSINESS WIRE)--BioIVT, the leading biospecimen solutions provider and global research partner for drug and diagnostic development, today announced it has appointed Sean Downing, PhD, to its Scientific Advisory Board to continue advancing the quality, characterization, and applicability of biospecimens. In addition, his appointment will enhance the integration of BioIVT’s richly annotated clinical data, multiomic insights, and biomarker expertise to enable more predictive and t...

BioIVT to Spotlight ADME-Tox Expertise and Solutions at Summer 2026 Events

WOODBURY, N.Y.--(BUSINESS WIRE)--BioIVT, the leading biospecimen solutions provider and global research partner for drug and diagnostic development, today announced it will showcase its broad portfolio of ADME-Tox solutions and research expertise at several leading industry events, including the 2026 MPS World Summit and the ISSX 16th European Meeting. The MPS World Summit takes place May 26-May 29, 2026, in Washington, D.C. BioIVT colleagues will be available at booth #115 to discuss research...
Back to Newsroom